| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A gain-of-function variant in the Wiskott-Aldrich syndrome gene is associated with a MYH9-related disease-like syndrome
|
Marx, David
|
|
|
6 |
18 |
p. 5279-5284
|
artikel
|
| 2 |
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial
|
Scarfò, Lydia
|
|
|
6 |
18 |
p. 5356-5359
|
artikel
|
| 3 |
A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma
|
Qualls, David
|
|
|
6 |
18 |
p. 5262-5266
|
artikel
|
| 4 |
Assessment of safety and immunogenicity of MHC homozygous iPSC-derived CD34+ hematopoietic progenitors in an NHP model
|
D'Souza, Saritha S.
|
|
|
6 |
18 |
p. 5267-5278
|
artikel
|
| 5 |
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
|
Villa, Diego
|
|
|
6 |
18 |
p. 5285-5294
|
artikel
|
| 6 |
Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease
|
Atiq, Ferdows
|
|
|
6 |
18 |
p. 5317-5326
|
artikel
|
| 7 |
Development of a carotid artery thrombolysis stroke model in mice
|
Maclean, Jessica A.A.
|
|
|
6 |
18 |
p. 5449-5462
|
artikel
|
| 8 |
Differential regulation of CTLA4 expression through BTK-dependent and independent mechanisms in CLL
|
Yano, Max
|
|
|
6 |
18 |
p. 5440-5448
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
6 |
18 |
p. i
|
artikel
|
| 10 |
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
|
Bichard, Christian
|
|
|
6 |
18 |
p. 5463-5466
|
artikel
|
| 11 |
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
|
Los-de Vries, G. Tjitske
|
|
|
6 |
18 |
p. 5482-5493
|
artikel
|
| 12 |
Genomic characterization of lymphomas in patients with inborn errors of immunity
|
Ye, Xiaofei
|
|
|
6 |
18 |
p. 5403-5414
|
artikel
|
| 13 |
Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome
|
Abu-Zeinah, Ghaith
|
|
|
6 |
18 |
p. 5477-5481
|
artikel
|
| 14 |
High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL
|
Chiodin, Giorgia
|
|
|
6 |
18 |
p. 5494-5504
|
artikel
|
| 15 |
International consensus statement on the management of cardiovascular risk of Bruton's tyrosine kinase inhibitors in CLL
|
Awan, Farrukh T.
|
|
|
6 |
18 |
p. 5516-5525
|
artikel
|
| 16 |
Loss of METTL3 attenuates blastic plasmacytoid dendritic cell neoplasm response to PRMT5 inhibition via IFN signaling
|
Rethnam, Malini
|
|
|
6 |
18 |
p. 5330-5344
|
artikel
|
| 17 |
Metabolic reprogramming under hypoxic storage preserves faster oxygen unloading from stored red blood cells
|
Rabcuka, Julija
|
|
|
6 |
18 |
p. 5415-5428
|
artikel
|
| 18 |
MicroRNA serum profiles and chronic graft-versus-host disease
|
Reikvam, Håkon
|
|
|
6 |
18 |
p. 5295-5306
|
artikel
|
| 19 |
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications
|
Döhner, Hartmut
|
|
|
6 |
18 |
p. 5345-5355
|
artikel
|
| 20 |
Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis
|
Rosenbaum, Cara A.
|
|
|
6 |
18 |
p. 5436-5439
|
artikel
|
| 21 |
Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis
|
Muchtar, Eli
|
|
|
6 |
18 |
p. 5429-5435
|
artikel
|
| 22 |
Phenotypic heterogeneity in individuals with MECOM variants in 2 families
|
Niihori, Tetsuya
|
|
|
6 |
18 |
p. 5257-5261
|
artikel
|
| 23 |
Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome–positive acute lymphoblastic leukemia
|
Ribera, Josep-Maria
|
|
|
6 |
18 |
p. 5395-5402
|
artikel
|
| 24 |
Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes
|
Kim, Yae-Jean
|
|
|
6 |
18 |
p. 5307-5316
|
artikel
|
| 25 |
Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
|
Abou-Ismail, Mouhamed Yazan
|
|
|
6 |
18 |
p. 5327-5329
|
artikel
|
| 26 |
Synonymous ADAMTS13 variants impact molecular characteristics and contribute to variability in active protein abundance
|
Jankowska, Katarzyna I.
|
|
|
6 |
18 |
p. 5364-5378
|
artikel
|
| 27 |
The potential role of protease systems in hemophilic arthropathy
|
Hauw, Wayne W.S.
|
|
|
6 |
18 |
p. 5505-5515
|
artikel
|
| 28 |
The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease
|
Ay, Cihan
|
|
|
6 |
18 |
p. 5467-5476
|
artikel
|
| 29 |
Upregulated SPAG6 promotes acute myeloid leukemia progression through MYO1D that regulates the EGFR family expression
|
Mu, Jiao
|
|
|
6 |
18 |
p. 5379-5394
|
artikel
|
| 30 |
Virtual frailty assessment for older adults with hematologic malignancies
|
DuMontier, Clark
|
|
|
6 |
18 |
p. 5360-5363
|
artikel
|
Tijdschrift beschrijving